# Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

> **NCT04097158** · — · RECRUITING · sponsor: **Loma Linda University** · enrollment: 160 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **OTHER:** Sample Collection

## Key facts

- **NCT ID:** NCT04097158
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-08
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-05-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04097158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04097158, "Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04097158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*